Role of MRI in Assessing the Feasibility of Fertility-Sparing Treatments for Early-Stage Endometrial and Cervical Cancers
American Journal of Roentgenology · 2025
DOI: 10.2214/ajr.24.32157 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Roentgenology, 2025. Verfasst von Mihan Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Uterine Cervical Neoplasms, Magnetic Resonance Imaging, Fertility Preservation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 97 Literaturangaben.
Abstract (Originalsprache)
Fertility-sparing treatment (FST) has become a key aspect of managing gynecologic cancers in reproductive-age patients who wish to preserve fertility. Several leading clinical societies, including the European Society of Gynecological Oncology, the European Society for Radiotherapy and Oncology, the European Society of Pathology, and the European Society of Human Reproduction and Embryology, have published evidence-based guidelines on fertility-sparing strategies and post-treatment surveillance of patients with early-stage gynecologic cancers, in particular endometrial and cervical cancers. These guidelines highlight MRI as essential to initial patient selection and follow-up. Properly tailored pelvic MRI protocols and clear MRI reports are key to performing accurate staging, assessing eligibility, and confirming the initial and ongoing feasibility of FST. Accordingly, radiologists, particularly those specializing in gynecologic imaging, play a critical role in the multidisciplinary approach to FST. They should be well-versed in FST eligibility criteria and key MRI findings before and after FST, ensuring these details are comprehensively communicated in structured MRI reports.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065.
- Department of Radiology, Weill Cornell Medical College, New York, NY.
- Department of Radiology, Mayo Clinic, Rochester, MN.
- Department of Radiology, PINKCC Laboratory, Montpellier Cancer Center, Montpellier, France.
- Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario, Rome, Italy.
- Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica Del Sacro Cuore, Rome, Italy.
Zitieren
APA
Lee, M., Andrieu, P. I. C., Nougaret, S., Russo, L., Moufarrij, S., Mueller, J. J., Abu-Rustum, N. R., Menias, C. O., & Lakhman, Y. (2025). Role of MRI in Assessing the Feasibility of Fertility-Sparing Treatments for Early-Stage Endometrial and Cervical Cancers. American Journal of Roentgenology. https://doi.org/10.2214/ajr.24.32157
Vancouver
Lee M, Andrieu PIC, Nougaret S, Russo L, Moufarrij S, Mueller JJ, et al. Role of MRI in Assessing the Feasibility of Fertility-Sparing Treatments for Early-Stage Endometrial and Cervical Cancers. American Journal of Roentgenology. 2025. doi:10.2214/ajr.24.32157
BibTeX
@article{Lee2025,
author = {Lee, Mihan and Andrieu, Pamela I Causa and Nougaret, Stephanie and Russo, Luca and Moufarrij, Sara and Mueller, Jennifer J and Abu-Rustum, Nadeem R and Menias, Christine O and Lakhman, Yulia},
title = {Role of MRI in Assessing the Feasibility of Fertility-Sparing Treatments for Early-Stage Endometrial and Cervical Cancers},
journal = {American Journal of Roentgenology},
year = {2025},
doi = {10.2214/ajr.24.32157}
}
EUVIMED